A phase II study of weekly low-dose paclitaxel plus 24-hour infusion of cisplatin as first-line chemotherapy for metastatic breast cancer (MBC)

被引：0
|
作者：
Shen, Y. [1 ]
Hsu, C. [1 ]
Kuo, S. [1 ]
Lu, Y. [1 ]
Lin, C. [1 ]
Huang, C. [1 ]
Cheng, A. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1100
引用
收藏
页数：1
相关论文
共 50 条
  • [41] First-line Bevacizumab Plus Taxane-based Chemotherapy for Metastatic Breast Cancer (mBC)
    Bazan, F.
    Dobi, E.
    Villanueva, C.
    Nerich, V.
    Compagnat, F.
    Thiery-Vuillemin, A.
    Chaigneau, L.
    Nguyen, T.
    Limat, S.
    Pivot, X.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S345 - S345
  • [42] BIWEEKLY PACLITAXEL AND CISPLATIN - A PHASE-I/II STUDY IN THE FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER
    OREILLY, SE
    GELMON, KA
    SEMINARS IN ONCOLOGY, 1995, 22 (03) : 109 - 111
  • [43] PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) AND WEEKLY PACLITAXEL (T) AS FIRST-LINE TREATMENT IN METASTATIC BREAST CANCER (MBC)
    Badalamenti, Giuseppe
    Valerio, Maria Rosaria
    Rinaldi, Gaetana
    Arcara, Carlo
    Cicero, Giuseppe
    Vizzini, Laura
    Travagliato, Maria Grazia
    Intrivici, Chiara
    Russo, Antonio
    Gulotta, Gaspare
    Gebbia, Nicola
    Fulfaro, Fabio
    ANNALS OF ONCOLOGY, 2004, 15 : 24 - 24
  • [44] IMP321 and weekly paclitaxel as first-line chemo-immunotherapy for metastatic breast cancer (MBC)
    Gutierrez, Maya
    Brignone, Chrystelle
    Grygar, Caroline
    Marcu, Manon
    Triebel, Frederic
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 873 - 873
  • [45] Irinotecan and low-dose capecitabine combination as first-line chemotherapy in advanced or metastatic gastric cancer: results of a phase II study
    Farhat, F.
    Kattan, J.
    Chahine, G.
    Naser, F.
    Youness, F.
    Ghosn, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 383 - 383
  • [46] Phase II study with dose finding of Oral Vinorelbine in combination with Capecitabine as first-line chemotherapy of Metastatic Breast Cancer (MBC): Preliminary results of the phase II part of the study
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 167 - 167
  • [47] Vinorelbine and paclitaxel as first-line chemotherapy in metastatic breast cancer
    Acuña, LR
    Langhi, M
    Pérez, J
    Acuña, JR
    Machiavelli, M
    Lacava, J
    Vallejo, C
    Romero, A
    Fasce, H
    Ortiz, E
    Grasso, S
    Amato, S
    Rodríguez, R
    Barbieri, M
    Leone, B
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) : 74 - 81
  • [48] Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: Phase I results
    Holmes, FA
    Valero, V
    Walters, RS
    Theriault, RL
    Booser, DJ
    Gibbs, H
    Fraschini, G
    Buzdar, AU
    Willey, J
    Frye, D
    Asmar, L
    Hortobagyi, GN
    ANNALS OF ONCOLOGY, 1999, 10 (04) : 403 - 411
  • [49] Combination versus sequential paclitaxel plus gemcitabine as first-line chemotherapy for women with metastatic breast cancer: a prospective randomized phase II study
    Shao, Bin
    Song, Guohong
    Li, Huiping
    Di, Lijun
    Jiang, Hanfang
    Liang, Xu
    Yan, Ying
    Zhang, Ruyan
    Ran, Ran
    Wang, Jing
    Liu, Xiaoran
    You, Miaoning
    JOURNAL OF BUON, 2018, 23 (06): : 1583 - 1590
  • [50] Phase II study of protracted irinotecan infusion and a low-dose cisplatin for metastatic gastric cancer
    Imamura, Hiroshi
    Ikeda, Masataka
    Furukawa, Hiroshi
    Tsujinaka, Toshimasa
    Fujitani, Kazumasa
    Kobayashi, Kenji
    Narahara, Hiroyuki
    Kato, Michio
    Imamoto, Haruhiko
    Takabayashi, Arimichi
    Tsukuma, Hideaki
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (40) : 6522 - 6526
12345